British homeopathy funding is 'bad medicine': Panel

Published on Mon, Feb 22, 2010 at 17:59 |  Source : Reuters

Updated at Mon, Feb 22, 2010 at 18:35  

Like this story, share it with millions of investors on M3
0
0
Share on Tumblr
British homeopathy funding is 'bad medicine': Panel

Britain should end its state funding for homeopathic treatments because they are "scientifically implausible" and work no better than placebos, an influential parliamentary panel said on Monday.

The Science and Technology committee said homeopathic products are not medicines and should no longer be licensed by medicines regulators.

Homeopathy producers should not be allowed to make medical claims on product labels without evidence they work, it added.

The committee accused the government of sending out mixed messages about homeopathic remedies by saying that while there is no evidence to back them, they can still be paid for by Britain's public National Health Service (NHS).

"It sets an unfortunate precedent for the department of health to consider that the existence of a community which believes that homeopathy works is 'evidence' enough to continue spending public money on it," committee chairman Phil Willis said in a statement. "This also sends out a confused message, and has potentially harmful consequences."

An election is due in Britain later this year and political leaders are under pressure to come up with any saving they can to bring down the country's ballooning public deficit.

Ministers estimate the NHS spends around 152,000 pounds (USD 235,000) - a tiny fraction of its around 100 billion pound budget - on homeopathic remedies each year.

In its report on homeopathy, the committee agreed with the government that evidence shows homeopathy is not efficacious - meaning it works no better than a placebo, or dummy pill.

"Explanations for why homeopathy would work are scientifically implausible," it said.

"Bad medicine"

Homeopathy, which originated in Germany in the 1700s, is based on a principle that "like cures like." The theory is that substances that prompt certain symptoms can also treat those same symptoms if given in a highly diluted form.

The practice is controversial because many of its central concepts do not accord with modern science. Many studies have found homeopathic remedies are no more effective than placebos.

Critics say the homeopathy industry has made millions out of selling little more than "sugar pills" to vulnerable patients.

Paula Ross, chief executive of the Society of Homeopaths, rejected the findings and accused the committee of wasting public money by turning its inquiry from one on the government's policy on homeopathy to one about whether homeopathy works - a question she said the committee was ill-equipped to answer.

"We would have preferred to see the government put money into much needed research into how actually homeopathy works," she said in a statement.

She argued that evidence shows homeopathy is effective beyond placebo, but "scientists have yet to understand how".

The committee said homeopathy was "a placebo treatment" and the government should have a policy on placebos - an area it said ministers were reluctant touch because prescribing placebos "usually relies on some degree of patient deception".

"Beyond ethical issues and the integrity of the doctor-patient relationship, prescribing pure placebos is bad medicine," it said.

  

Trending News

Business News

Tim Cook speaks candidly about Apple at D10
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!